EGFR and neoplasm: When SERS gold nanoparticles were injected through the tail vein of mice, the nanoparticles were targeted to bind to EGFR positive tumor cells and located in intracellular organelles, such as endosomes and lysosomes, while accumulation was hardly observed in the brain, muscle, or other major organs.